Centurium Capital Partners 2018, L.P.

Completed

Going privateGoing private (SC 13E3)

Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)
Exchange: —
State of incorporation: E9
Form: SC 13E3
Filed: February 14, 2020

Deal approval & antitrust

merger-arb risk

A change of control closes only once its regulators clear it. These agencies have jurisdiction given the company's sector — track each one's docket for this deal. We link the official source; we do not assert an outcome.

FTC ↗Antitrust / competition review (Hart-Scott-Rodino)DOJ Antitrust Division ↗Antitrust / competition review (Hart-Scott-Rodino)

Filings & documents

Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.

Source filing ↗SC 13E3 · the filing we parse All documents in this filing ↗accession 0001104659-20-022026 Centurium Capital Partners 2018, L.P. — all SEC filings ↗EDGAR company page